June 09, 2025 16:05 ET | Source: Lyell Immunopharma, Inc Mark J. Bachleda, PharmD, MBA appointed as independent member of…
June 06, 2025 16:07 ET | Source: Restem MIAMI, June 06, 2025 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology…
STUTTGART, Germany, June 5, 2025 /PRNewswire/ -- Highstar launched its next-generation Tabless Cell series under the theme "Tabless Forest, Vitality Reborn"…
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)…
World's Largest Supplier of Cell Spacers Delivering OEMs a Full Portfolio of Advanced Thermal Solutions IRVING, Texas, June 4, 2025…
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease Fourth orphan drug designation for rilzabrutinib in rare…
46% reduction in the risk of disease progression or death, and 27% reduction in the risk of death, in an…
Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33 heavily pretreated patients with metastatic melanoma demonstrates favorable…